Related Experiment Video

Updated: Sep 26, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.5K

Patient attendance at molecular tumor board: A new means of shared decision making?

Timothy Lewis Cannon1, Laura Knopp2, Hongkun Wang3

  • 1Department of Oncology, Associate Professor University of Virginia, Inova Schar Cancer Institute, Fairfax, VA.

Current Problems in Cancer
|April 18, 2022
PubMed

Insights

Patient participation in medical decisions enhances outcomes. Attending a molecular tumor board (MTB) significantly improved patients' understanding and satisfaction with targeted therapy knowledge.

Area of Science:

  • Oncology
  • Genomics
  • Patient Engagement

Background:

  • Patient engagement in medical decision-making is crucial for improving outcomes like compliance and satisfaction.
  • The Inova Schar Cancer Institute utilizes a weekly molecular tumor board (MTB) to align comprehensive genomic sequencing with targeted therapies.
  • Oncologists invited patients to attend the MTB sessions.

Discussion:

  • A study evaluated patient satisfaction with targeted therapy information before and after MTB attendance.
  • A statistically significant improvement in patient satisfaction regarding their knowledge of targeted therapy was observed (P=0.016).
  • Patients attending the MTB reported increased satisfaction with their understanding of targeted therapy.

Key Insights:

  • Molecular tumor board attendance positively impacts patient satisfaction with knowledge of targeted therapies.
  • Enhanced patient understanding of targeted therapy can lead to better engagement in treatment decisions.
  • The MTB serves as a valuable platform for personalized cancer treatment discussions.

Outlook:

  • Future research should involve larger patient populations to validate these findings.
  • A formal evaluation of physician experiences with patient participation in the MTB is recommended.
  • Exploring broader impacts of patient engagement in molecular tumor boards on treatment adherence and outcomes is warranted.
Keywords:
DNAMolecular profilingPatient engagementPrecision medicineSequencing

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
689
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K